Emerging CAR T cell therapies: clinical landscape and patent technological routes-Reference-Cited by-同舟云学术

Emerging CAR T cell therapies: clinical landscape and patent technological routes

Published:2019-12-06 Issue:6 Volume:16 Page:1424-1433
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Picanco-Castro Virgínia¹^ORCID,Gonçalves Pereira Cristiano²^ORCID,Swiech Kamilla¹³^ORCID,Ribeiro Malmegrim Kelen Cristina¹³^ORCID,Tadeu Covas Dimas¹^ORCID,Silveira Porto Geciane²⁴^ORCID

Affiliation:

1. Center for Cell-based Therapy CTC, Regional Blood Center of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil

2. School of Economics, Business Administration and Accounting, University of São Paulo, Ribeirão Preto, São Paulo, Brazil

3. School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil

4. Institute of Advanced Studies of the University of São Paulo IEA/USP, Ribeirão Preto, São Paulo, Brazil

Funder

São Paulo Research Grants Foundation

National Council for Scientific and Technological Development

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2019.1689744

Reference25 articles.

1. Engineered T cells: the promise and challenges of cancer immunotherapy

2. Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity.

3. Eshhar Z, Waks T, Gross G, Schindler DG. Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors. Proc Natl Acad Sci U S A. 1993;90(2):720–24.

4. Expression in cytotoxic T lymphocytes of a single-chain anti-carcinoembryonic antigen antibody. Redirected Fas ligand-mediated lysis of colon carcinoma

5. Activation of Resting Human Primary T Cells with Chimeric Receptors: Costimulation from CD28, Inducible Costimulator, CD134, and CD137 in Series with Signals from the TCRζ Chain

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non‐industrial production of therapeutic lentiviral vectors: How to provide vectors to academic CAR‐T;Biotechnology and Bioengineering;2024-07-04

2. Cryopreserved leukapheresis material can be transferred from controlled rate freezers to ultracold storage at warmer temperatures without affecting downstream CAR-T cell culture performance and in-vitro functionality;Cryobiology;2024-06

3. Car T Cells in Solid Tumors: Overcoming Obstacles;International Journal of Molecular Sciences;2024-04-10

4. Unlocking the value of innovative medicines: Insights from the advanced therapy medicinal products (ATMP) innovation systems in Germany and Sweden;Health Policy and Technology;2023-06

5. CAR T-cell Therapy of Hematologic Malignancies: An Update in Targeted Antigens;Iranian Journal of Pediatric Hematology & Oncology;2023-03-28